Simplifying Global Compliance
GHTF Guidance Asks Devicemakers to Report All Trial Adverse Events
Devices & Diagnostics Letter
Medical devicemakers should report all adverse events in premarket clinical trials and any device deficiencies that might lead to a serious adverse event (SAE), according to the Global Harmonization Task Force’s (GHTF) final guidance on reportable events.
To View This Article:
Subscribe To Devices & Diagnostics Letter
Buy This Article Now
Copyright ©2018. All Rights Reserved.
Design, CMS, Hosting & Web Development :: ePublishing